| Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations G Brix, U Lechel, G Glatting, SI Ziegler, W Münzing, SP Müller, T Beyer Journal of Nuclear Medicine 46 (4), 608-613, 2005 | 641 | 2005 |
| Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG AK Buck, G Halter, H Schirrmeister, J Kotzerke, I Wurziger, G Glatting, ... Journal of nuclear medicine 44 (9), 1426-1431, 2003 | 544 | 2003 |
| Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET H Schirrmeister, A Guhlmann, K Elsner, J Kotzerke, G Glatting, ... Journal of Nuclear Medicine 40 (10), 1623-1629, 1999 | 432 | 1999 |
| FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters A Buck, H Schirrmeister, T Kühn, C Shen, T Kalker, J Kotzerke, A Dankerl, ... European journal of nuclear medicine and molecular imaging 29, 1317-1323, 2002 | 376 | 2002 |
| Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer H Schirrmeister, G Glatting, J Hetzel, K Nüssle, C Arslandemir, AK Buck, ... Journal of Nuclear Medicine 42 (12), 1800-1804, 2001 | 363 | 2001 |
| Imaging prostate cancer with 11C-choline PET/CT SN Reske, NM Blumstein, B Neumaier, HW Gottfried, F Finsterbusch, ... Journal of Nuclear Medicine 47 (8), 1249-1254, 2006 | 360 | 2006 |
| Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography H Schirrmeister, A Guhlmann, J Kotzerke, C Santjohanser, T Kuhn, ... Journal of Clinical Oncology 17 (8), 2381-2381, 1999 | 337 | 1999 |
| 2‐(fluorine‐18)fluoro‐2‐deoxy‐D‐glucose positron emission tomography in the detection and staging of malignant lymphoma: A bicenter trial I Buchmann, M Reinhardt, K Elsner, D Bunjes, C Altehoefer, J Finke, ... Cancer 91 (5), 889-899, 2001 | 335 | 2001 |
| Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures H Schirrmeister, T Kühn, A Guhlmann, C Santjohanser, T Hörster, ... European journal of nuclear medicine 28, 351-358, 2001 | 329 | 2001 |
| EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry C Hindorf, G Glatting, C Chiesa, O Lindén, G Flux European journal of nuclear medicine and molecular imaging 37, 1238-1250, 2010 | 311 | 2010 |
| 3-deoxy-3-[18F] fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules AK Buck, H Schirrmeister, M Hetzel, M Von Der Heide, G Halter, ... Cancer research 62 (12), 3331-3334, 2002 | 306 | 2002 |
| Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma SN Reske, KG Grillenberger, G Glatting, M Port, M Hildebrandt, ... Journal of Nuclear Medicine 38 (9), 1344-1348, 1997 | 292 | 1997 |
| Choosing the optimal fit function: comparison of the Akaike information criterion and the F‐test G Glatting, P Kletting, SN Reske, K Hohl, C Ring Medical physics 34 (11), 4285-4292, 2007 | 275 | 2007 |
| FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies CG Diederichs, L Staib, G Glatting, HG Beger, SN Reske Journal of Nuclear Medicine 39 (6), 1030-1033, 1998 | 265 | 1998 |
| Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis A Guhlmann, D Brecht-Krauss, G Suger, G Glatting, J Kotzerke, L Kinzl, ... Journal of Nuclear Medicine 39 (12), 2145-2152, 1998 | 264 | 1998 |
| Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. A Guhlmann, D Brecht-Krauss, G Suger, G Glatting, J Kotzerke, L Kinzl, ... Radiology 206 (3), 749-754, 1998 | 247 | 1998 |
| Values and limitations of 18F-fluorodeoxyglucose–positron-emission tomography with preoperative evaluation of patients with pancreatic masses CG Diederichs, L Staib, J Vogel, B Glasbrenner, G Glatting, HJ Brambs, ... Pancreas 20 (2), 109-116, 2000 | 222 | 2000 |
| Molecular imaging of proliferation in malignant lymphoma AK Buck, M Bommer, S Stilgenbauer, M Juweid, G Glatting, ... Cancer research 66 (22), 11055-11061, 2006 | 218 | 2006 |
| 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. JC Stollfuss, G Glatting, H Friess, F Kocher, HG Berger, SN Reske Radiology 195 (2), 339-344, 1995 | 208 | 1995 |
| Intraindividual comparison of [11C] acetate and [11C] choline PET for detection of metastases of prostate cancer J Kotzerke, BG Volkmer, G Glatting, J Van Den Hoff, JE Gschwend, ... Nuklearmedizin-NuclearMedicine 42 (01), 25-30, 2003 | 207 | 2003 |
Bernd NeumaierInstitute of Neuroscience and Medicine INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbHDirección de correo verificada de uk-koeln.de
